Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Mar;53(3):1295-6.
doi: 10.1128/AAC.01097-08. Epub 2008 Dec 15.

In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group

Luis A Arroyo, Ingeborg Mateos, Verónica González, Javier Aznar

In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group

Luis A Arroyo et al. Antimicrob Agents Chemother. 2009 Mar.
No abstract available

PubMed Disclaimer

References

    1. Anthony, K. B., N. O. Fishman, D. R. Linkin, L. B. Gasink, P. H. Edelstein, and E. Lautenbach. 2008. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. Clin. Infect. Dis. 46:567-570. - PubMed
    1. Arroyo, L. A., A. García-Curiel, M. E. Pachón-Ibañez, A. C. Llanos, M. Ruiz, J. Pachón, and J. Aznar. 2005. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43:903-905. - PMC - PubMed
    1. Hawley, J. S., C. K. Murray, and J. H. Jorgensen. 2008. Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy. Antimicrob. Agents Chemother. 52:351-352. - PMC - PubMed
    1. Karageorgopoulos, D. E., T. Kelesidis, I. Kelesidis, and M. E. Falagas. 2008. Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J. Antimicrob. Chemother. 62:45-55. - PMC - PubMed
    1. Matthaiou, D. K., A. Michalopoulos, P. I. Rafailidis, D. E. Karageorgopoulos, V. Papaioannou, G. Ntani, G. Samonis, and M. E. Falagas. 2008. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit. Care Med. 36:807-811. - PubMed

Publication types

MeSH terms